THE PREPARATION OF LIGANDIN WITH GLUTATHIONE-S-TRANSFERASE ACTIVITY FROM PORCINE LIVER CYTOSOL BY AFFINITY CHROMATOGRAPHY ON BROMOSULPHOPHTHALEIN-SEPHAROSE.GRAHNEN A; SJOHOLM I.1977; EUROP. J. BIOCHEM.; GERM.; DA. 1977; VOL. 80; NO 2; PP. 573-580; BIBL. 37 REF.Article

Cimetidine bioavailability and variable renal clearanceGRAHNEN, A.European journal of clinical pharmacology. 1984, Vol 27, Num 5, pp 623-624, issn 0031-6970Article

Pharmacokinetic strategies of drug control in Sweden. Principal aspects with special emphasis on bioavailabilityGRAHNEN, A.Acta pharmaceutica suecica. 1984, Vol 21, Num 4, issn 0001-6675, 256Article

DETERMINATION OF UNCONJUGATED BILIRUBIN IN HUMAN SERUM BY OPTICAL ROTATION MEASUREMENTSBERGLOEF J; GRAHNEN A; SJOHOLM I et al.1975; CLIN. CHIM. ACTA; PAYS-BAS; DA. 1975; VOL. 62; NO 1; PP. 169-172; BIBL. 4REFArticle

DETERMINATION OF LIGANDIN-LIKE PROTEINS AND SERUM ALBUMIN BY DIFFERENTIAL SPECTROSCOPY WITH BROMSULPHOPHTHALEIN.SJOHOLM I; ANDREASSON J; GRAHNEN A et al.1975; ACTA PHARM. SUCCINA; SUEDE; DA. 1975; VOL. 12; NO 3; PP. 253-258; BIBL. 19 REF.Article

PRAZOSIN DYNAMICS IN HYPERTENSION: RELATIONSHIP TO PLASMA CONCENTRATIONSEIDEMAN P; GRAHNEN A; HAGLUND K et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 4; PP. 447-454; BIBL. 29 REF.Article

PRAZOSIN FIRST DOSE PHENOMENON DURING COMBINED TREATMENT WITH A BETA -ADRENOCEPTOR BLOCKER IN HYPERTENSIVE PATIENTSSEIDEMAN P; GRAHNEN A; HAGLUND K et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 6; PP. 865-870; BIBL. 21 REF.Article

PRAZOSIN KINETICS IN HYPERTENSIONGRAHNEN A; SEIDEMAN P; LINDSTROEM B et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 4; PP. 439-446; BIBL. 26 REF.Article

BIOAVAILABILITY AND PHARMACOKINETICS OF CIMETIDINEGRAHNEN A; VON BAHR C; LINDSTROM B et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 5; PP. 335-340; BIBL. 22 REF.Article

Effect of loracarbef on the normal oropharyngeal and intestinal microfloraNORD, C. E; GRAHNEN, A; ECKERNAS, S.-A et al.Scandinavian journal of infectious diseases. 1991, Vol 23, Num 2, pp 255-260, issn 0036-5548Article

Steady-state kinetics of sustained-release phenylpropanolamineLONNERHOLM, G; GRAHNEN, A; LINDSTROM, B et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 1, pp 39-41, issn 0174-4879Article

Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteersHEDENSTRÖM, H; ALM, C; KRAFT, M et al.Alimentary pharmacology & therapeutics. 1997, Vol 11, Num 6, pp 1137-1141, issn 0269-2813Article

Impact of dirithromycin on the normal oral and intestinal microfloraECKERNAS, S. A; GRAHNEN, A; NORD, C. E et al.European journal of clinical microbiology & infectious diseases (Print). 1991, Vol 10, Num 8, pp 688-692, issn 0934-9723Article

Implications of intraindividual variability in bioavailability studies of furosemideGRAHNEN, A; HAMMARLUND, M; LUNDQVIST, T et al.European journal of clinical pharmacology. 1984, Vol 27, Num 5, pp 595-602, issn 0031-6970Article

Pharmacokinetics of terbutaline during pregnancyLYRENAS, S; GRAHNEN, A; LINDBERG, B et al.European journal of clinical pharmacology. 1986, Vol 29, Num 5, pp 619-623, issn 0031-6970Article

Chloroquine excretion following malaria prophylaxisGUSTAFSSON, L. L; LINDSTROM, B; GRAHNEN, A et al.British journal of clinical pharmacology. 1987, Vol 24, Num 2, pp 221-224, issn 0306-5251Article

Doxycycline carrageenate : an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrateGRAHNEN, A; OLSSON, B; JOHANSSON, G et al.European journal of clinical pharmacology. 1994, Vol 46, Num 2, pp 143-146, issn 0031-6970Article

Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effectALVAN, G; PAINTAUD, G; ECLERNÄS, S.-Å et al.British journal of clinical pharmacology. 1992, Vol 34, Num 1, pp 47-52, issn 0306-5251Article

Inter- and intraindividual variability in the concentration-effect (sedation) relationship of flunitrazepamGRAHNEN, A; WENNERLUND, P; DAHLSTROÊM, B et al.British journal of clinical pharmacology. 1991, Vol 31, Num 1, pp 89-92, issn 0306-5251, 4 p.Article

Adverse effects of cosmetics and toiletries reported to the Swedish Medical Products Agency 1989-1994BERNE, B; BOSTRÖM, A; GRAHNEN, A. F et al.Contact dermatitis. 1996, Vol 34, Num 5, pp 359-362, issn 0105-1873Article

Pharmacokinetic profile of recombinant human insulin-like growth factor I given subcutaneously in normal subjectsWILTON, P; SIETNIEKS, A; GUNNARSSON, R et al.Acta paediatrica Scandinavica. Supplement. 1991, Num 377, pp 111-114, issn 0300-8843Conference Paper

Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failureSALMONSON, T; DANIELSON, B. G; GRAHNEN, A et al.Journal of internal medicine. 1990, Vol 228, Num 1, pp 53-57, issn 0954-6820Article

Pharmacokinetics of cimetidine in advanced cirrhosisGRAHNEN, A; JAMESON, S; LOOF, L et al.European journal of clinical pharmacology. 1984, Vol 26, Num 3, pp 347-355, issn 0031-6970Article

Nonlinearity of amoxicillin absorption kinetics in humanPAINTAUD, G; ALVAN, G; DAHL, M. L et al.European journal of clinical pharmacology. 1992, Vol 43, Num 3, pp 283-288, issn 0031-6970Article

Pharmacokinetics of intraarticular indomethacin in patients with osteoarthritisNEANDER, G; ERIKSSON, L.-O; WÅLLIN-BOLL, E et al.European journal of clinical pharmacology. 1992, Vol 42, Num 3, pp 301-305, issn 0031-6970Article